Design, Synthesis and Biological Investigation of 2-Anilino Triazolopyrimidines as Tubulin Polymerization Inhibitors with Anticancer Activities
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Design, Synthesis and Biological Investigation of 2-Anilino Triazolopyrimidines as Tubulin Polymerization Inhibitors with Anticancer Activities
Authors
Keywords
-
Journal
Pharmaceuticals
Volume 15, Issue 8, Pages 1031
Publisher
MDPI AG
Online
2022-08-22
DOI
10.3390/ph15081031
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Design, synthesis, biological assessment, and in-Silico studies of 1,2,4-triazolo[1,5-a]pyrimidine derivatives as tubulin polymerization inhibitors
- (2022) Heba S. Mohamed et al. BIOORGANIC CHEMISTRY
- Synthesis and Biological Evaluation of Highly Active 7-Anilino Triazolopyrimidines as Potent Antimicrotubule Agents
- (2022) Paola Oliva et al. Pharmaceutics
- Taxanes in cancer treatment: Activity, chemoresistance and its overcoming
- (2021) Luciana Mosca et al. DRUG RESISTANCE UPDATES
- Discovery of Novel Benzimidazole and Indazole Analogues as Tubulin Polymerization Inhibitors with Potent Anticancer Activities
- (2021) Yichang Ren et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of highly potent tubulin polymerization inhibitors: Design, synthesis, and structure-activity relationships of novel 2,7-diaryl-[1,2,4]triazolo[1,5-a]pyrimidines
- (2021) Xian-Sen Huo et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, and Biological Evaluation of Stable Colchicine-Binding Site Tubulin Inhibitors 6-Aryl-2-benzoyl-pyridines as Potential Anticancer Agents
- (2021) Hao Chen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Microtubule-targeting agents and their impact on cancer treatment
- (2020) Vladimír Čermák et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Synthesis and Biological Evaluation of 2-Substituted Benzyl-/Phenylethylamino-4-amino-5-aroylthiazoles as Apoptosis-Inducing Anticancer Agents
- (2020) Paola Oliva et al. MOLECULES
- The role of CDC25C in cell cycle regulation and clinical cancer therapy: a systematic review
- (2020) Kai Liu et al. Cancer Cell International
- Bevacizumab plus fosbretabulin in recurrent ovarian cancer: Overall survival and exploratory analyses of a randomized phase II NRG oncology/gynecologic oncology group study
- (2020) Krishnansu S. Tewari et al. GYNECOLOGIC ONCOLOGY
- The Mechanism of Tubulin Assembly into Microtubules: Insights from Structural Studies
- (2020) Marcel Knossow et al. iScience
- Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins
- (2019) Rumani Singh et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy
- (2019) Kinsie E Arnst et al. MEDICINAL RESEARCH REVIEWS
- Regulating the BCL2 Family to Improve Sensitivity to Microtubule Targeting Agents
- (2019) Robert H. Whitaker et al. Cells
- Combretastatin-based compounds with therapeutic characteristics: a patent review
- (2019) Lalit Mohan Nainwal et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Tubulin inhibitors as novel anticancer agents: an overview on patents (2013-2018)
- (2019) Kashif Haider et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Novel [1,2,4]triazolo[1,5-a]pyrimidine derivatives as potent antitubulin agents: Design, multicomponent synthesis and antiproliferative activities
- (2019) Fang Yang et al. BIOORGANIC CHEMISTRY
- Reversible binding of the anticancer drug KXO1 (tirbanibulin) to the colchicine-binding site of β-tubulin explains KXO1's low clinical toxicity
- (2019) Lu Niu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead
- (2018) Emanuela Martino et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Recent advances in microtubule-stabilizing agents
- (2018) Ya-Nan Cao et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Microtubule-Targeting Agents: Strategies To Hijack the Cytoskeleton
- (2018) Michel O. Steinmetz et al. TRENDS IN CELL BIOLOGY
- A phase I/II study of fosbretabulin in combination with everolimus in neuroendocrine tumors that have progressed after at least one prior regimen for metastatic disease.
- (2018) Aman Chauhan et al. JOURNAL OF CLINICAL ONCOLOGY
- Tubulin inhibitors targeting the colchicine binding site: a perspective of privileged structures
- (2017) Wenlong Li et al. Future Medicinal Chemistry
- Taxol®: The First Microtubule Stabilizing Agent
- (2017) Chia-Ping Yang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Microtubule destabilising agents: far more than just antimitotic anticancer drugs
- (2016) Darcy Bates et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Recent Advancement in Discovery and Development of Natural Product Combretastatin-inspired Anticancer Agents
- (2015) Pravin Patil et al. Anti-Cancer Agents in Medicinal Chemistry
- Antimitotic drugs in the treatment of cancer
- (2015) Rustelle Janse van Vuuren et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Tubulins - The Target for Anticancer Therapy
- (2015) N.G. Vindya et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Control of microtubule organization and dynamics: two ends in the limelight
- (2015) Anna Akhmanova et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Structural Optimization of Indole Derivatives Acting at Colchicine Binding Site as Potential Anticancer Agents
- (2015) Dong-Jin Hwang et al. ACS Medicinal Chemistry Letters
- Microtubule-targeting agents are clinically successful due to both mitotic and interphase impairment of microtubule function
- (2014) Jessica J. Field et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Recent developments in tubulin polymerization inhibitors: An overview
- (2014) Ramandeep Kaur et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis, Antimitotic and Antivascular Activity of 1-(3′,4′,5′-Trimethoxybenzoyl)-3-arylamino-5-amino-1,2,4-triazoles
- (2014) Romeo Romagnoli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, and Biological Evaluation of Stable Colchicine Binding Site Tubulin Inhibitors as Potential Anticancer Agents
- (2014) Yan Lu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting Microtubules by Natural Agents for Cancer Therapy
- (2014) E. Mukhtar et al. MOLECULAR CANCER THERAPEUTICS
- Design, synthesis and biological evaluation of 3,5-disubstituted 2-amino thiophene derivatives as a novel class of antitumor agents
- (2013) Romeo Romagnoli et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Tubulin: an example of targeted chemotherapy
- (2013) Jenny Seligmann et al. Future Medicinal Chemistry
- Concise Synthesis and Biological Evaluation of 2-Aroyl-5-Amino Benzo[b]thiophene Derivatives As a Novel Class of Potent Antimitotic Agents
- (2013) Romeo Romagnoli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Molecular Mechanism of Action of Microtubule-Stabilizing Anticancer Agents
- (2013) A. E. Prota et al. SCIENCE
- Critical role of anti-apoptotic Bcl-2 protein phosphorylation in mitotic death
- (2013) J M Eichhorn et al. Cell Death & Disease
- Structural plasticity of tubulin assembly probed by vinca-domain ligands
- (2012) Fanomezana M. Ranaivoson et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Tubulin-based Structure-affinity Relationships for Antimitotic Vinca Alkaloids
- (2012) Claire Coderch et al. Anti-Cancer Agents in Medicinal Chemistry
- Tubulins as Therapeutic Targets in Cancer: from Bench to Bedside
- (2012) Christos D. Katsetos et al. CURRENT PHARMACEUTICAL DESIGN
- Discovery and Optimization of a Series of 2-Aryl-4-Amino-5-(3′,4′,5′-trimethoxybenzoyl)Thiazoles as Novel Anticancer Agents
- (2012) Romeo Romagnoli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Novel Tubulin Polymerization Inhibitors Overcome Multidrug Resistance and Reduce Melanoma Lung Metastasis
- (2012) Zhao Wang et al. PHARMACEUTICAL RESEARCH
- An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding Site
- (2012) Yan Lu et al. PHARMACEUTICAL RESEARCH
- Microtubule-targeted agents: When mitochondria become essential to chemotherapy
- (2011) A. Rovini et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Classification of scaffold-hopping approaches
- (2011) Hongmao Sun et al. DRUG DISCOVERY TODAY
- Synthesis and apoptosis inducing ability of new anilino substituted pyrimidine sulfonamides as potential anticancer agents
- (2011) Ahmed Kamal et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Drugs that target dynamic microtubules: A new molecular perspective
- (2011) Richard A. Stanton et al. MEDICINAL RESEARCH REVIEWS
- Drug Metabolism and Pharmacokinetics of 4-Substituted Methoxybenzoyl-aryl-thiazoles
- (2010) C.-M. Li et al. DRUG METABOLISM AND DISPOSITION
- Synthesis and biological evaluation of 2-(3′,4′,5′-trimethoxybenzoyl)-3-aryl/arylaminobenzo[b]thiophene derivatives as a novel class of antiproliferative agents
- (2010) Romeo Romagnoli et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Combretastatin A4 phosphate: a novel vascular disrupting agent
- (2010) Govardhanan Nagaiah et al. Future Oncology
- Microtubule-binding agents: a dynamic field of cancer therapeutics
- (2010) Charles Dumontet et al. NATURE REVIEWS DRUG DISCOVERY
- Class III β-tubulin expression and in vitro resistance to microtubule targeting agents
- (2009) C Stengel et al. BRITISH JOURNAL OF CANCER
- Is class III β-tubulin a predictive factor in patients receiving tubulin-binding agents?
- (2008) Pascal Sève et al. LANCET ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started